In addition, it addresses the FDA’s communications Together with the applicant, the retention of records that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of an SE report back to a different applicant and electronic submission from the SE